Amaryl Related Clinical Trials
Exenatide Versus Glimepiride in Patients With Type 2 Diabetes [Active, not recruiting]
Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg [Completed]
Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg [Completed]
Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR) [Completed]
Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia [Active, not recruiting]
Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation (PERISCOPE) [Completed]
Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus [Recruiting]
Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride [Recruiting]
Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients [Recruiting]
Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil) [Completed]
Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects [Recruiting]
To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c [Active, not recruiting]
Efficacy Study of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus. [Recruiting]
24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes [Completed]
Avandiaâ„¢ + Amarylâ„¢ or Avandametâ„¢ Compared With Metformin (AVALANCHEâ„¢ Study) [Completed]
Study Comparing Efficacy and Safety of Amaryl M and Metformin Uptitraion to Type 2 DM [Recruiting]
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes (LEAD 1) [Completed]
Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione [Completed]
Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass [Recruiting]
Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects [Not yet recruiting]
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes (LEAD-5) [Completed]
A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes [Active, not recruiting]
To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together [Active, not recruiting]
Study of the Durability of Glycemic Control With Nateglinide [Not yet recruiting]
Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM) [Recruiting]
Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes Patients [Recruiting]
Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin [Completed]
Safety and Efficacy of Inhaled Pre-Prandial Human Insulin in Type 2 Diabetes [Terminated]
Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes [Recruiting]
CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride [Recruiting]
Glimepiride Vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus [Completed]
A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin. [Recruiting]
Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus [Recruiting]
A Randomised, db, Placebo-Controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-Blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate [Recruiting]
Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes [Terminated]
Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes. [Completed]
Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination Compared to Glimepiride in Patients With Type 2 Diabetes Mellitus [Not yet recruiting]
Effect of Inhaled Pre-Prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes [Terminated]
LANN-Study: Lantus, Amaryl, Novorapid, Novomix Study [Recruiting]
A Study to Test MK0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin [Recruiting]
Efficacy Study of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia. [Recruiting]
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin [Recruiting]
Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes [Completed]
Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride [Completed]
How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin. [Recruiting]
Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes [Active, not recruiting]
Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes [Completed]
Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress [Not yet recruiting]
Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone [Completed]
A Study of Pioglitazone HCl Versus Glimepiride in Subjects With Type 2 Diabetes Measuring the Progression of Atherosclerosis (CHICAGO) [Completed]
Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes [Completed]
Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin) [Recruiting]
Insulin Glargine During and After the Period of Fasting in Ramadan [Completed]
Efficacy and Safety of BI 1356 BS in Combination With Metformin in Patients With type2 Diabetes [Completed]
Anti-Inflammatory Effects of Pioglitazone [Recruiting]
A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control [Active, not recruiting]
Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus [Completed]
Bioequivalence Study of SB797620 in Healthy Japanese Volunteers [Terminated]
Short-Term Intensive Insulin Therapy Induction of Long-Term Glycemic Control [Recruiting]
Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT) [Active, not recruiting]
Correlation of Plasma Endothelial Cell Activity With Cardiovascular Events in Patients With Diabetes Mellitus Type 2 [Active, not recruiting]
Non-Traditional Cardiovascular Risk Factors and Atherosclerosis in Type 2 Diabetes [Active, not recruiting]
Fatty Acid Binding Protein 2 (FABP2) Ancillary Proposal [Active, not recruiting]
Markers and Mechanisms of Vascular Disease in Type II Diabetes [Active, not recruiting]
Insulin Glulisine in Type 2 Diabetic Patients [Active, not recruiting]
The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus [Recruiting]
Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study) [Recruiting]
Effect of Sitagliptin on Postprandial Lipoprotein Metabolism [Not yet recruiting]
Secondary Prevention in Coronary Heart Disease [Recruiting]
Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents [Not yet recruiting]
Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy [Recruiting]
Insulin Glargine "All to Target" Trial [Recruiting]
|
